These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 1476671)
21. The construction of a mouse/human chimeric antibody against human breast cancer cells. Meulemans E; Vandevyver C; Volckaert G; Raus J Year Immunol; 1993; 7():131-6. PubMed ID: 8372502 [No Abstract] [Full Text] [Related]
22. The tyrosine residue at position 97 in the VH CDR3 region of a mouse/human chimeric anti-colorectal carcinoma antibody contributes hydrogen bonding to the TAG72 antigen. Xiang J; Liu E; Delbaere LT; Chen Z; Luo X; Qi Y; Rathgeber C Cancer Biother; 1993; 8(3):253-62. PubMed ID: 7804366 [TBL] [Abstract][Full Text] [Related]
23. Differences in antigen-binding affinity caused by a single amino acid substitution in the variable region of the heavy chain. Xiang J; Chen Z; Delbaere LT; Liu E Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():239-47. PubMed ID: 8225393 [TBL] [Abstract][Full Text] [Related]
24. Production of hybrid bispecific antibody recognizing human colorectal carcinoma and CD3 antigen. Xiang J; Pan Z; Attah-Poku S; Babiuk L; Zhang Y; Liu E Mol Biother; 1992 Mar; 4(1):15-23. PubMed ID: 1385710 [TBL] [Abstract][Full Text] [Related]
26. Cloning and high level expression of a chimeric antibody with specificity for human carcinoembryonic antigen. Beidler CB; Ludwig JR; Cardenas J; Phelps J; Papworth CG; Melcher E; Sierzega M; Myers LJ; Unger BW; Fisher M J Immunol; 1988 Dec; 141(11):4053-60. PubMed ID: 3141512 [TBL] [Abstract][Full Text] [Related]
27. Characterization of a mouse/human chimeric monoclonal antibody (17-1A) to a colon cancer tumor-associated antigen. Shaw DR; Khazaeli MB; Sun LK; Ghrayeb J; Daddona PE; McKinney S; LoBuglio AF J Immunol; 1987 Jun; 138(12):4534-8. PubMed ID: 3584980 [TBL] [Abstract][Full Text] [Related]
28. Production of murine V-human Cr1 chimeric anti-TAG72 antibody using V region cDNA amplified by PCR. Xiang JH; Roder J; Hozumi N Mol Immunol; 1990 Aug; 27(8):809-17. PubMed ID: 2119481 [TBL] [Abstract][Full Text] [Related]
29. Cloning and expression of the H chain V region of antibody OVB3 that reacts with human ovarian cancer. Gallo MG; Chaudhary VK; Fitzgerald DJ; Willingham MC; Pastan I J Immunol; 1988 Aug; 141(3):1034-40. PubMed ID: 3135309 [TBL] [Abstract][Full Text] [Related]
30. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells. Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465 [TBL] [Abstract][Full Text] [Related]
31. [Construction of expression vector for human-mouse chimeric antibody and expression of an antibody against human HER2]. Wang LL; Han H Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):363-5. PubMed ID: 15193240 [TBL] [Abstract][Full Text] [Related]
32. [Cloning and expression of heavy- and light-chain variable region genes of monoclonal antibody specific for human fibrin]. Song Z; Cai Y; Song D; Xu J; Wang L; Yuan H; Liu J; Zhang Y; Lin H Zhonghua Xue Ye Xue Za Zhi; 1997 Jun; 18(6):311-4. PubMed ID: 15622627 [TBL] [Abstract][Full Text] [Related]
33. [Cloning fragments of cDNA coding variable segments of light and heavy chains of monoclonal antibodies against human interleukin-2]. Paskhin AI; Golovina TN; Nesmeianov VA; Korobko VG Bioorg Khim; 1995 Jun; 21(6):430-5. PubMed ID: 7661867 [TBL] [Abstract][Full Text] [Related]
34. Gangliosides, Ab1 and Ab2 antibodies II. Light versus heavy chain: An idiotype-anti-idiotype case study. López-Requena A; Rodríguez M; de Acosta CM; Moreno E; Puchades Y; González M; Talavera A; Valle A; Hernández T; Vázquez AM; Pérez R Mol Immunol; 2007 Feb; 44(5):1015-28. PubMed ID: 16620986 [TBL] [Abstract][Full Text] [Related]
35. Cloning of cDNAs encoding the variable domains of antibody KC4G3 and construction of a chimeric antibody. Couto JR; Blank EW; Peterson JA; Ceriani RL Hybridoma; 1993 Aug; 12(4):485-9. PubMed ID: 8244420 [TBL] [Abstract][Full Text] [Related]
36. [Development of genetically engineered chimeric and single chain antibodies against human brain glioma: a preliminary report]. Huang Q; Shen S; Xu Z Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):259-62. PubMed ID: 9387315 [TBL] [Abstract][Full Text] [Related]
37. Targeting gamma interferon to tumor cells by a genetically engineered fusion protein secreted from myeloma cells. Xiang J; Qi Y; Cook D; Moyana T Hum Antibodies Hybridomas; 1996; 7(1):2-10. PubMed ID: 8886831 [TBL] [Abstract][Full Text] [Related]
38. Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas. Liao SK; Horton L; Flahart RE; O'Rear L; Crumpacker D; Imbaratto JW; Yannelli JR; Robinson RR; Oldham RK Hum Antibodies Hybridomas; 1990; 1(2):66-76. PubMed ID: 2103354 [TBL] [Abstract][Full Text] [Related]
39. Self-reactive antibody expression by human carcinoma cells engineered with monoclonal antibody genes. Primus FJ; Finch MD; Masci AM; Schlom J; Kashmiri SV Cancer Res; 1993 Jul; 53(14):3355-61. PubMed ID: 8324746 [TBL] [Abstract][Full Text] [Related]
40. Amino acid sequence of a phosphocholine-binding antibody from an immune defective CBA/N mouse employing the T15 VH region associated with unusual DH, JH, and V kappa segments. Clarke SH; Kenny JJ; Sieckmann DG; Rudikoff S J Immunol; 1984 Mar; 132(3):1544-9. PubMed ID: 6420465 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]